53 Results for "

APJ

" in MedChemExpress (MCE) Product Catalog:
Products (53)

53 Results for "APJ" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-P1944
CAS No.: 217082-58-1
Apelin-13 is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 is widely distributed in the central and peripheral nervous systems. Apelin-13 has vasodilatory and antihypertensive effects. Apelin-13 also can be used for researching type 2 diabetes and metabolic syndrome .
loading...
    loading...
10
10 Publications Verification
Cat. No.: HY-P1944A
Apelin-13 TFA is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 TFA has vasodilatory and antihypertensive effects. Apelin-13 TFA also can be used for researching type 2 diabetes and metabolic syndrome .
loading...
    loading...
10
10 Publications Verification
Cat. No.: HY-103254
CAS No.: 877636-42-5
Purity:  99.55%
Research Areas:  

Neurological Disease

ML221 is a potent apelin (APJ) functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC80 of 10 nM in both assays.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P2106
CAS No.: 1886973-05-2
Research Areas:  

Cardiovascular Disease

Elabela(19-32) is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P2106A
Research Areas:  

Cardiovascular Disease

Elabela(19-32) TFA is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) TFA activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) TFA induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P1033
CAS No.: 217082-60-5
Synonyms: [pGlu1]-Apelin-13
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

[Pyr1]-Apelin-13 is a highly potent, selective endogenous apelin receptor (APJ) agonist.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-122197
CAS No.: 2579689-83-9
Purity:  99.88%
Research Areas:  

Cancer

ML339 is a selective CXCR6 antagonist with an IC50 of 140 nM. ML339 antagonizes β-arrestin recruitment and cAMP signaling pathway of human CXCR6 receptor induced by CXCL16, with IC50 of 0.3 μM and 1.4 μM, respectively. ML339 shows weaker activity against the recruitment of β-arrestin in mouse CXCR6 receptors, with an IC50 of 18 μM. ML339 has no inhibitory effect on CXCR5CXCR4CXCR6 and apelin receptor (APJ), with IC50 >79 μM. ML339 has the potential to promote the development of prostate cancer research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2537
CAS No.: 229961-08-4
Research Areas:  

Others

Apelin-12 is one of the most potent C-terminal fragments of the polypeptide that possesses a high affinity to orphan receptor APJ receptor. Apelin-12 is involved in the regulation of body fluid homeostasis and in the central control of feeding. Apelin-12 blocks HIV-1 entry through APJ receptor. Apelin-12 exerts neuroprotective effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7061A
Research Areas:  

Infection Endocrinology

ALX 40-4C Trifluoroacetate is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also acts as an antagonist of the APJ receptor, with an IC50 of 2.9 μM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P77874
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Apelin; APJ endogenous ligand; APEL
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-139485
CAS No.: 2055200-88-7
Purity:  99.33%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

BMS-986224 is a potent, selective and orally active APJ receptor agonist (Kd = 0.3 nM). BMS-986224 exhibits similar receptor binding and signaling profile to (Pyr 1) apelin-13. BMS-986224 has the potential for the research of heart failure .
loading...
    loading...
Cat. No.: HY-103080
CAS No.: 1586787-08-7
Purity:  99.89%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

CMF019 is an orally active, potent and small molecule agonist at Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ with pKi values of 8.58, 8.49 and 8.71 for human, rat, and mouse, respectively. CMF019 mimics the beneficial cardiovascular actions of apelin in rodents . Apelin receptor (APJ) is a G protein-coupled receptor (GPCR) activated by the endogenous peptide apelin. CMF019 is promising for research of chronic diseases, such as, pulmonary arterial hypertension .
loading...
    loading...
Cat. No.: HY-170419
CAS No.: 3037373-19-3
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

APJ receptor agonist 10 is an agonist of the APJ Receptor. APJ receptor agonist 10 can be used for research on pulmonary arterial hypertension .
loading...
    loading...
Cat. No.: HY-125976
CAS No.: 2080311-92-6
Purity:  99.8%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

ML233 is a non-peptide based potent apelin receptor (APJ) agonist (EC50=3.7 μM). ML233 displays >21-fold selective over the closely related angiotensin 1 (AT1) receptor (>79 μM) .
loading...
    loading...
Cat. No.: HY-P1066
CAS No.: 217082-57-0
Research Areas:  

Infection

Apelin-17(human, bovine) is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-17(human, bovine) binds to human APJ receptors expressed in HEK 293 cells (pIC50=9.02). Apelin-17(human, bovine) inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .
loading...
    loading...
Cat. No.: HY-P2271
CAS No.: 1313027-43-8
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cancer

MM 54 (compound 5) is a competitive antagonist at APJ, with an IC50 of 93 nM. MM 54 behaves as a potent and selective inhibitor of apelin binding and APLNR activation .
loading...
    loading...
Cat. No.: HY-P1064
CAS No.: 252642-12-9
Apelin-36(human) is an endogenous orphan G protein-coupled receptor APJ agonist, with an EC50 of 20 nM. Apelin-36(human) shows high affinity to human APJ receptors expressed in HEK 293 cells (pIC50=8.61). Apelin-36 has been linked to two major types of biological activities: cardiovascular and metabolic. Apelin-36(human) inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .
loading...
    loading...
Cat. No.: HY-P1065
CAS No.: 230299-95-3
Apelin-36(rat, mouse) is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-36(rat, mouse) binds to APJ receptors with an IC50 of 5.4 nM, and potently inhibits cAMP production with an EC50 of 0.52 nM. Apelin-36(rat, mouse) blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ .
loading...
    loading...
Cat. No.: HY-P3162A
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

(Ala13)-Apelin-13 TFA is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 TFA inhibits gastric motility through vagal cholinergic pathway .
loading...
    loading...
Cat. No.: HY-147751
CAS No.: 1965244-85-2
Research Areas:  

Cardiovascular Disease

APJ receptor agonist 6 (compound 9) is a potent APJ (apelin receptor) agonist, with Ki of 1.3 μM. APJ receptor agonist 6 has EC50 values of 0.070 , 0.097, and 0.063 μM for calcium, cAMP, and β-arrestin, respectively .
loading...
    loading...